{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:42:17Z","timestamp":1792237337681,"version":"4.4.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ophtha.2026.09.021","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:19:15Z","timestamp":1792235955000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Between Scylla and Charybdis: Weighing Salvage and Loss in Retinoblastoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-9100","authenticated-orcid":false,"given":"Jesse L.","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.09.021_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2026.07.015","article-title":"Eye-preserving therapies for early cT3c retinoblastoma","author":"Xu","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.09.021_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ceo.70090","article-title":"Saving the eye, counting the cost: rethinking treatment burden in unilateral retinoblastoma","volume":"54","author":"Berry","year":"2026","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.09.021_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IIO.0000000000000265","article-title":"An intraocular pressure predictive of high-risk histopathologic features in group E retinoblastoma eyes","volume":"59","author":"Kim","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2026.09.021_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/08820538.2024.2447724","article-title":"Primary enucleation for intraocular unilateral retinoblastoma can save life in lower-income settings","volume":"40","author":"Arazi","year":"2025","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.09.021_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajo.2023.11.020","article-title":"Aqueous humor liquid biopsy as a companion diagnostic for retinoblastoma: implications for diagnosis, prognosis, and therapeutic options: five years of progress","volume":"263","author":"Berry","year":"2024","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026006949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026006949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:19:16Z","timestamp":1792235956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026006949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":5,"alternative-id":["S0161642026006949"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.09.021","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Between Scylla and Charybdis: Weighing Salvage and Loss in Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.07.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}